Ledger.Open graph →
SEC Form D · filed October 3, 2014

Solstice Biologics LLC

Offering
$7.5M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert S. Adelman · San Francisco, CADirectorFrank Muhlenbeck · BEDFORD, MADirectorSteven Dowdy · San Francisco, CADirectorCurt Bradshaw · San Fransisco, CADirectorCorey Goodman · Suite 595, CAExec · DirectorGoldwater Fund GP LLC · NEW YORK, NYDirectorJoseph J. Glatt · Dublin 2, IrelandDirectorSeth W. Alvord · WESTPORT, CTDirectorJustin W. Kaplan · WESTPORT, CTDirectorJohn Borgeson · San Jose, CAExecLouis Tartaglia · Boston, MADirectorRobin P. Selati · CHICAGO, ILDirectorGoldwater Asset Management LP · NEW YORK, NYExec · DirectorScott Kilpatrick · Phoenix, AZDirectorJeffery D. Peters · Pittsburgh, PADirectorTodd D. Belfer · Scottsdale, AZExec · DirectorJohn Borgeson · San Francisco, CAExecLouis Tartaglia · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗